Samba O. Sow

18.8k total citations · 1 hit paper
151 papers, 3.3k citations indexed

About

Samba O. Sow is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Samba O. Sow has authored 151 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 74 papers in Infectious Diseases and 37 papers in Microbiology. Recurrent topics in Samba O. Sow's work include Bacterial Infections and Vaccines (37 papers), Pneumonia and Respiratory Infections (37 papers) and Viral gastroenteritis research and epidemiology (31 papers). Samba O. Sow is often cited by papers focused on Bacterial Infections and Vaccines (37 papers), Pneumonia and Respiratory Infections (37 papers) and Viral gastroenteritis research and epidemiology (31 papers). Samba O. Sow collaborates with scholars based in Mali, United States and United Kingdom. Samba O. Sow's co-authors include Milagritos D. Tapia, Karen L. Kotloff, Myron M. Levine, Boubou Tamboura, Zulfiqar A Bhutta, James P. Nataro, Keith P. Klugman, Carol Tévi‐Bénissan, Rabab Jafri and Florence Fermon and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Samba O. Sow

145 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccines and therapeutics for immunocompromised patients with COVID-19

2023 66 citations Shmuel Shoham, Carolina Batista et al. EClinicalMedicine profile →

Peers

Countries citing papers authored by Samba O. Sow

Since Specialization

Citations

This map shows the geographic impact of Samba O. Sow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samba O. Sow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samba O. Sow more than expected).

Fields of papers citing papers by Samba O. Sow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samba O. Sow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samba O. Sow. The network helps show where Samba O. Sow may publish in the future.

Co-authorship network of co-authors of Samba O. Sow

This figure shows the co-authorship network connecting the top 25 collaborators of Samba O. Sow. A scholar is included among the top collaborators of Samba O. Sow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samba O. Sow. Samba O. Sow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Personalized azithromycin treatment rules for children with watery diarrhea using machine learning	Nature Communications	Sara Kim, Patricia B. Pavlinac et al.	0
2	WHO Workshop Report: Regulatory Science to Inform Clinical Pathways for Shigella Vaccines Intended for Use in Children in Low- and Middle-Income Countries	Vaccines	Robert W. Kaminski, Patricia B. Pavlinac et al.	0
3	Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial	The Lancet	Fatoumata Diallo, Fadima Cheick Haidara et al.	2
4	Ethical clinical trial design and differences in treatment effects	Bulletin of the World Health Organization	Roger Lewis, Kert Viele et al.	0
5	Qualitative evaluation of a package of implementation strategies codesigned to support the introduction of multiple micronutrient supplementation (MMS) for pregnant women in Bamako, Mali	Maternal and Child Nutrition	Monica Fox, Adama Mamby Keita et al.	0
6	Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa	Nature Communications	Nicaise Ndembi, Morẹ́nikẹ́ Oluwátóyìn Foláyan et al.	5
7	Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study	EClinicalMedicine	Fadima Cheick Haidara, Milagritos D. Tapia et al.	5
8	Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic		Prashant Yadav, Carolina Batista et al.	1
9	Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence	SHILAP Revista de lepidopterología	Justin R. Ortiz, Steven M. Brunwasser et al.	1
10	Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in Mali	BMJ Open	Amanda J. Driscoll, Fadima Cheick Haidara et al.	5
11	Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis	SHILAP Revista de lepidopterología	Ranju Baral, Andrea G. Buchwald et al.	7
12	Vaccines and therapeutics for immunocompromised patients with COVID-19 breakdown →	EClinicalMedicine	Shmuel Shoham, Carolina Batista et al.	66
13	SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021	BMJ Open	Dagmar Alber, Fadima Cheick Haidara et al.	3
14	Urgent needs to accelerate the race for COVID-19 therapeutics	EClinicalMedicine	Carolina Batista, Shmuel Shoham et al.	8
15	Serological Protection 5–6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes	Frontiers in Immunology	Olubukola T. Idoko, Cristina Domingo et al.	5
16	Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt	PLoS ONE	Odile B. Harrison, Jay Lucidarme et al.	13
17	Rationale and design of the African group A streptococcal infection registry: the AFRO Strep study	BMJ Open	Mark E. Engel, Andrew Whitelaw et al.	11
18	Global epidemiology of invasive meningococcal disease	Population Health Metrics	Rabab Jafri, Asad Ali et al.	283
19	Background Rates of Adverse Pregnancy Outcomes for Assessing the Safety of Maternal Vaccine Trials in Sub-Saharan Africa	PLoS ONE	Lauren A.V. Orenstein, Evan Orenstein et al.	13
20	Age-specific prevalence estimates and risk factors for asymptomatic Neisseria meningitidis carriage in Bamako, Mali	International Journal of Infectious Diseases	Nicole E. Basta, Samba O. Sow et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact